--
-- PostgreSQL database dump
--

-- Dumped from database version 15.6
-- Dumped by pg_dump version 16.1

SET statement_timeout = 0;
SET lock_timeout = 0;
SET idle_in_transaction_session_timeout = 0;
SET client_encoding = 'UTF8';
SET standard_conforming_strings = on;
SELECT pg_catalog.set_config('search_path', '', false);
SET check_function_bodies = false;
SET xmloption = content;
SET client_min_messages = warning;
SET row_security = off;

--
-- Data for Name: t_attachments; Type: TABLE DATA; Schema: public; Owner: d3l243
--

COPY public.t_attachments (attachment_id, attachment_type, attachment_name, attachment_description, owner_username, active, contents, file_name, created) FROM stdin;
100	MRM Transition List	abs_VP2P105_MRM_transitions_optV_set1	Transitions for the human proteins:,ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n488.73,701.32,17\r\n488.73,630.28,17\r\n488.73,573.26,17\r\n488.73,458.24,17\r\n488.73,343.21,17\r\n599.86,881.53,20\r\n599.86,784.48,20\r\n599.86,697.45,20\r\n599.86,584.36,20\r\n599.86,485.29,20\r\n599.86,272.17,20\r\n586.29,1034.51,20\r\n586.29,906.45,20\r\n586.29,849.43,20\r\n586.29,750.36,20\r\n586.29,619.32,20\r\n758.38,1216.59,25\r\n758.38,1079.53,25\r\n758.38,942.47,25\r\n758.38,841.42,25\r\n758.38,694.35,25\r\n1085.21,1251.64,32\r\n1085.21,1063.06,32\r\n1085.21,1277.72,32\r\n1085.21,753.39,32\r\n1085.21,553.27,32\r\n1085.21,390.21,32\r\n895.95,1411.75,29\r\n895.95,1086.59,29\r\n895.95,802.44,29\r\n895.95,689.36,29\r\n895.95,588.31,29\r\n895.95,475.23,29\r\n895.95,1298.67,29\r\n1061.88,1356.68,31\r\n1061.88,1291.16,31\r\n1061.88,806.95,31\r\n1061.88,1110.64,31\r\n1061.88,819.52,31\r\n1061.88,706.44,31\r\n977.54,1291.76,32\r\n977.54,1095.64,32\r\n977.54,869.47,32\r\n977.54,639.38,32\r\n977.54,568.35,32\r\n977.54,471.29,32\r\n	abs_VP2P105_MRM_transitions_optV_set1.csv	2009-08-05 10:25:45
101	MRM Transition List	abs_VP2P105_MRM_transitions_optV_set2	Transitions for the human proteins:,ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n1346.3,1312.7,39\r\n1346.3,1241.66,39\r\n1346.3,1113.67,39\r\n1346.3,1044.51,39\r\n1346.3,759.38,39\r\n917.46,1406.68,30\r\n917.46,1335.64,30\r\n917.46,1248.61,30\r\n917.46,1088.58,30\r\n917.46,987.53,30\r\n882.4,1264.52,29\r\n882.4,1101.46,29\r\n882.4,986.43,29\r\n882.4,743.35,29\r\n882.4,596.28,29\r\n865.79,1192.11,26\r\n865.79,1301.69,26\r\n865.79,1170.65,26\r\n865.79,968.55,26\r\n865.79,661.39,26\r\n765.9,1233.63,25\r\n765.9,1162.59,25\r\n765.9,1048.55,25\r\n765.9,949.48,25\r\n765.9,862.45,25\r\n765.9,549.28,25\r\n808.42,1318.63,27\r\n808.42,1219.56,27\r\n808.42,1104.54,27\r\n808.42,991.45,27\r\n808.42,862.41,27\r\n660.36,860.49,22\r\n660.36,713.42,22\r\n660.36,626.39,22\r\n660.36,527.32,22\r\n660.36,428.25,22\r\n810.92,1370.69,27\r\n810.92,1223.62,27\r\n810.92,1076.56,27\r\n810.92,945.52,27\r\n810.92,573.34,27\r\n533.22,820.34,18\r\n533.22,689.3,18\r\n533.22,618.27,18\r\n533.22,547.23,18\r\n533.22,794.26,18\r\n848.92,1245.66,28\r\n848.92,870.48,28\r\n848.92,684.4,28\r\n848.92,571.32,28\r\n848.92,1126.52,28\r\n933.45,1327.65,27\r\n933.45,1113.05,27\r\n933.45,618.79,27\r\n933.45,1236.58,27\r\n933.45,1089.51,27\r\n933.45,760.37,27\r\n933.45,689.34,27\r\n	abs_VP2P105_MRM_transitions_optV_set2.csv	2009-08-05 10:26:55
102	MRM Transition List	abs_VP2P105_MRM_transitions_optV_set3	Transitions for the human proteins:,ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n692.31,1099.47,23\r\n692.31,971.41,23\r\n692.31,856.38,23\r\n692.31,437.25,23\r\n692.31,338.18,23\r\n689.83,1182.52,23\r\n689.83,1081.48,23\r\n689.83,982.41,23\r\n689.83,822.38,23\r\n689.83,723.31,23\r\n526.76,995.49,18\r\n526.76,898.44,18\r\n526.76,801.39,18\r\n526.76,730.35,18\r\n526.76,616.31,18\r\n526.76,559.28,18\r\n526.76,488.25,18\r\n526.76,359.2,18\r\n526.76,262.15,18\r\n490.26,922.49,17\r\n490.26,759.43,17\r\n490.26,646.34,17\r\n490.26,559.31,17\r\n490.26,462.26,17\r\n490.26,347.23,17\r\n490.26,234.15,17\r\n929.44,1233.63,30\r\n929.44,1120.54,30\r\n929.44,1006.5,30\r\n929.44,674.38,30\r\n929.44,561.3,30\r\n739.35,1378.62,25\r\n739.35,1281.57,25\r\n739.35,1180.52,25\r\n739.35,1049.48,25\r\n739.35,889.45,25\r\n739.35,790.38,25\r\n739.35,675.36,25\r\n739.35,489.28,25\r\n739.35,402.25,25\r\n739.35,288.2,25\r\n	abs_VP2P105_MRM_transitions_optV_set3.csv	2009-08-05 10:27:10
103	MRM Transition List	abs_VP2P105_MRM_transitions_optV_set4	Transitions for the human proteins:,ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n767.39,1335.63,25\r\n767.39,1220.61,25\r\n767.39,1123.55,25\r\n767.39,1022.51,25\r\n767.39,925.45,25\r\n767.39,796.41,25\r\n767.39,668.35,25\r\n767.39,521.28,25\r\n767.39,393.22,25\r\n767.39,322.19,25\r\n1015,1342.68,33\r\n1015,1205.62,33\r\n1015,1074.58,33\r\n1015,975.51,33\r\n1015,888.48,33\r\n1015,787.43,33\r\n1015,686.38,33\r\n1015,573.3,33\r\n1015,476.25,33\r\n1015,377.18,33\r\n677.01,971.49,20\r\n677.01,920.97,20\r\n677.01,877.45,20\r\n677.01,826.93,20\r\n677.01,778.4,20\r\n677.01,721.38,20\r\n677.01,671.84,20\r\n677.01,603.31,20\r\n677.01,537.79,20\r\n677.01,488.26,20\r\n677.01,1205.62,20\r\n677.01,1074.58,20\r\n677.01,975.51,20\r\n677.01,888.48,20\r\n677.01,787.43,20\r\n677.01,686.38,20\r\n677.01,573.3,20\r\n677.01,476.25,20\r\n677.01,377.18,20\r\n677.01,262.15,20\r\n433.75,719.42,15\r\n433.75,606.34,15\r\n433.75,493.25,15\r\n433.75,379.21,15\r\n433.75,322.19,15\r\n	abs_VP2P105_MRM_transitions_optV_set4.csv	2009-08-05 10:27:25
104	MRM Transition List	abs_VP2P105_MRM_transitions_optV_set5	Transitions for the human proteins:,ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n485.75,869.45,17\r\n485.75,756.37,17\r\n485.75,669.34,17\r\n485.75,555.29,17\r\n485.75,498.27,17\r\n485.75,351.2,17\r\n485.75,294.18,17\r\n1370.64,1328.66,44\r\n1370.64,1214.62,44\r\n1370.64,1100.57,44\r\n1370.64,987.49,44\r\n1370.64,900.46,44\r\n1370.64,803.41,44\r\n1370.64,702.36,44\r\n1370.64,645.34,44\r\n1370.64,459.26,44\r\n1370.64,372.22,44\r\n914.1,1327.13,27\r\n914.1,1258.6,27\r\n914.1,1215.08,27\r\n914.1,1150.56,27\r\n914.1,1107.05,27\r\n914.1,1071.53,27\r\n914.1,1028.01,27\r\n914.1,979.48,27\r\n914.1,935.97,27\r\n914.1,900.45,27\r\n914.1,1328.66,27\r\n914.1,1214.62,27\r\n914.1,1100.57,27\r\n914.1,987.49,27\r\n914.1,900.46,27\r\n914.1,803.41,27\r\n914.1,702.36,27\r\n914.1,645.34,27\r\n914.1,459.26,27\r\n914.1,372.22,27\r\n914.1,244.17,27\r\n466.77,720.37,16\r\n466.77,649.33,16\r\n466.77,534.31,16\r\n466.77,786.42,16\r\n466.77,658.32,16\r\n	abs_VP2P105_MRM_transitions_optV_set5.csv	2009-08-05 10:27:45
137	MRM Transition List	OPN_c	For Dian Su, sample contains OPN_c, request# x	D3E154	Y	1468.655\n734.8312\n490.2235\n1160.5264\n774.0199\n1612.7201\n1075.4823\n806.864\n1089.4645\n726.6454\n545.2363\n1058.9669\n706.3137\n529.9875\n927.9527\n618.9709\n464.4804	OPN_c.csv	2010-12-28 11:47:10
105	MRM Transition List	abs_VP2P105_MRM_transitions_optV_set6	Transitions for the human proteins:,ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n674.37,1234.64,23\r\n674.37,1147.61,23\r\n674.37,1018.57,23\r\n674.37,905.48,23\r\n674.37,848.46,23\r\n674.37,777.43,23\r\n674.37,720.4,23\r\n674.37,606.36,23\r\n674.37,549.34,23\r\n674.37,492.32,23\r\n647.81,1009.48,22\r\n647.81,896.4,22\r\n647.81,768.31,22\r\n647.81,538.25,22\r\n647.81,423.22,22\r\n913.97,1373.67,30\r\n913.97,1226.61,30\r\n913.97,1139.57,30\r\n913.97,1026.49,30\r\n913.97,897.45,30\r\n674.34,1159.6,23\r\n674.34,1030.55,23\r\n674.34,917.47,23\r\n674.34,802.44,23\r\n674.34,731.41,23\r\n674.34,674.38,23\r\n674.34,560.34,23\r\n674.34,503.32,23\r\n674.34,446.3,23\r\n674.34,347.23,23\r\n736.89,1230.65,25\r\n736.89,1101.61,25\r\n736.89,1030.57,25\r\n736.89,917.48,25\r\n736.89,770.42,25\r\n736.89,713.39,25\r\n736.89,585.34,25\r\n736.89,488.28,25\r\n736.89,389.21,25\r\n736.89,290.15,25\r\n912.93,1224.57,30\r\n912.93,1095.53,30\r\n912.93,996.46,30\r\n912.93,881.43,30\r\n912.93,734.37,30\r\n912.93,663.33,30\r\n912.93,606.31,30\r\n834.88,1224.57,27\r\n834.88,1095.53,27\r\n834.88,996.46,27\r\n834.88,881.43,27\r\n834.88,734.37,27\r\n834.88,663.33,27\r\n834.88,606.31,27\r\n	abs_VP2P105_MRM_transitions_optV_set6.csv	2009-08-05 10:27:55
106	MRM Transition List	abs_VP2P105_MRM_transitions_optV_set7	Transitions for the human proteins:,ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n449.77,785.44,16\r\n449.77,688.39,16\r\n449.77,559.35,16\r\n449.77,430.3,16\r\n449.77,317.22,16\r\n449.77,204.13,16\r\n492.27,870.44,17\r\n492.27,756.4,17\r\n492.27,628.34,17\r\n492.27,531.29,17\r\n492.27,474.27,17\r\n492.27,373.22,17\r\n492.27,276.17,17\r\n651.92,1189.74,22\r\n651.92,1076.66,22\r\n651.92,939.6,22\r\n651.92,826.51,22\r\n651.92,697.47,22\r\n651.92,584.39,22\r\n651.92,456.29,22\r\n715.96,1189.74,24\r\n715.96,1076.66,24\r\n715.96,939.6,24\r\n715.96,826.51,24\r\n715.96,697.47,24\r\n715.96,584.39,24\r\n715.96,456.29,24\r\n1187.56,1410.7,38\r\n1187.56,1297.62,38\r\n1187.56,1069.51,38\r\n1187.56,851.44,38\r\n1187.56,780.4,38\r\n499.27,834.47,17\r\n499.27,737.42,17\r\n499.27,624.34,17\r\n499.27,527.28,17\r\n499.27,430.23,17\r\n499.27,333.18,17\r\n499.27,218.15,17\r\n926.47,1371.66,30\r\n926.47,1224.59,30\r\n926.47,1123.54,30\r\n926.47,1026.49,30\r\n926.47,911.46,30\r\n926.47,764.39,30\r\n926.47,636.34,30\r\n926.47,507.29,30\r\n926.47,360.22,30\r\n926.47,261.16,30\r\n	abs_VP2P105_MRM_transitions_optV_set7.csv	2009-08-05 10:28:05
107	MRM Transition List	abs_VP2P105_MRM_transitions_optV_set8	Transitions for the human proteins:,ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n554.29,978.53,19\r\n554.29,865.44,19\r\n554.29,752.36,19\r\n554.29,605.29,19\r\n554.29,476.25,19\r\n554.29,347.2,19\r\n554.29,246.16,19\r\n855.48,1406.78,28\r\n855.48,1269.72,28\r\n855.48,1140.67,28\r\n855.48,913.55,28\r\n855.48,800.46,28\r\n570.65,781.94,17\r\n570.65,703.89,17\r\n570.65,635.36,17\r\n570.65,570.84,17\r\n570.65,513.82,17\r\n570.65,913.55,17\r\n570.65,800.46,17\r\n570.65,743.44,17\r\n570.65,630.36,17\r\n570.65,516.31,17\r\n487.76,917.48,17\r\n487.76,789.43,17\r\n487.76,690.36,17\r\n487.76,543.29,17\r\n487.76,428.26,17\r\n487.76,329.19,17\r\n487.76,272.17,17\r\n674.88,1107.57,23\r\n674.88,978.53,23\r\n674.88,865.44,23\r\n674.88,752.36,23\r\n674.88,605.29,23\r\n674.88,476.25,23\r\n450.25,618.34,14\r\n450.25,554.29,14\r\n450.25,489.77,14\r\n450.25,433.22,14\r\n450.25,376.68,14\r\n450.25,303.15,14\r\n450.25,1107.57,14\r\n450.25,978.53,14\r\n450.25,865.44,14\r\n450.25,752.36,14\r\n	abs_VP2P105_MRM_transitions_optV_set8.csv	2009-08-05 10:28:16
109	MRM Transition List	abs_VP2P105_MRM_transitions_optV_set10	Transitions for the human proteins:,ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n1072.51,1257.65,35\r\n1072.51,1156.6,35\r\n1072.51,1099.58,35\r\n1072.51,952.51,35\r\n1072.51,839.43,35\r\n1072.51,738.38,35\r\n1072.51,609.34,35\r\n1072.51,446.27,35\r\n1072.51,347.2,35\r\n1072.51,276.17,35\r\n715.34,1022.97,21\r\n715.34,987.45,21\r\n715.34,929.94,21\r\n715.34,881.41,21\r\n715.34,823.9,21\r\n715.34,755.37,21\r\n715.34,697.86,21\r\n715.34,629.33,21\r\n715.34,578.8,21\r\n715.34,550.29,21\r\n715.34,1257.65,21\r\n715.34,1156.6,21\r\n715.34,1099.58,21\r\n715.34,952.51,21\r\n715.34,839.43,21\r\n715.34,738.38,21\r\n715.34,609.34,21\r\n715.34,446.27,21\r\n715.34,347.2,21\r\n715.34,276.17,21\r\n1161.08,1275.66,37\r\n1161.08,952.56,37\r\n1161.08,805.49,37\r\n1161.08,692.41,37\r\n1161.08,529.35,37\r\n774.39,1275.66,23\r\n774.39,1115.63,23\r\n774.39,1046.53,23\r\n774.39,978,23\r\n774.39,921.45,23\r\n	abs_VP2P105_MRM_transitions_optV_set10.csv	2009-08-05 10:28:40
110	MRM Transition List	abs_VP2P105_MRM_transitions_optV_set11	Transitions for the human proteins:,ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n1149.57,1388.74,37\r\n1149.57,1275.66,37\r\n1149.57,952.56,37\r\n1149.57,805.49,37\r\n1149.57,692.41,37\r\n766.72,1042.03,23\r\n766.72,978,23\r\n766.72,921.45,23\r\n766.72,1275.66,23\r\n766.72,1115.63,23\r\n766.72,529.35,23\r\n766.72,401.29,23\r\n442.78,755.51,16\r\n442.78,642.43,16\r\n442.78,514.37,16\r\n442.78,401.29,16\r\n442.78,288.2,16\r\n553.8,977.54,19\r\n553.8,864.46,19\r\n553.8,751.37,19\r\n553.8,604.31,19\r\n553.8,476.25,19\r\n553.8,347.2,19\r\n553.8,246.16,19\r\n486.75,915.47,17\r\n486.75,787.41,17\r\n486.75,690.36,17\r\n486.75,543.29,17\r\n486.75,428.26,17\r\n486.75,329.19,17\r\n486.75,272.17,17\r\n1086.52,1257.65,35\r\n1086.52,1156.6,35\r\n1086.52,1099.58,35\r\n1086.52,952.51,35\r\n1086.52,839.43,35\r\n1086.52,738.38,35\r\n1086.52,609.34,35\r\n1086.52,446.27,35\r\n1086.52,347.2,35\r\n1086.52,276.17,35\r\n724.68,1029.98,22\r\n724.68,994.46,22\r\n724.68,936.95,22\r\n724.68,888.42,22\r\n724.68,823.9,22\r\n724.68,755.37,22\r\n724.68,697.86,22\r\n724.68,1257.65,22\r\n724.68,1156.6,22\r\n724.68,1099.58,22\r\n724.68,952.51,22\r\n724.68,839.43,22\r\n724.68,738.38,22\r\n724.68,609.34,22\r\n724.68,446.27,22\r\n724.68,347.2,22\r\n724.68,276.17,22\r\n	abs_VP2P105_MRM_transitions_optV_set11.csv	2009-08-05 10:28:50
111	MRM Transition List	abs_VP2P105_MRM_transitions_optV_set12	Transitions for the human proteins:,ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n922.99,1391.72,30\r\n922.99,1190.64,30\r\n922.99,1077.56,30\r\n922.99,964.48,30\r\n922.99,851.39,30\r\n605.33,933.5,21\r\n605.33,796.44,21\r\n605.33,709.41,21\r\n605.33,638.37,21\r\n605.33,524.33,21\r\n403.89,523.8,13\r\n403.89,467.25,13\r\n403.89,398.73,13\r\n403.89,355.21,13\r\n403.89,319.69,13\r\n403.89,262.67,13\r\n403.89,213.14,13\r\n403.89,156.59,13\r\n403.89,1046.59,13\r\n403.89,933.5,13\r\n403.89,796.44,13\r\n403.89,709.41,13\r\n403.89,638.37,13\r\n403.89,524.33,13\r\n403.89,425.26,13\r\n403.89,312.18,13\r\n783.36,1121.48,26\r\n783.36,992.44,26\r\n783.36,855.38,26\r\n783.36,727.32,26\r\n783.36,626.27,26\r\n783.36,463.21,26\r\n522.58,726.82,16\r\n522.58,683.3,16\r\n522.58,634.78,16\r\n522.58,561.24,16\r\n522.58,496.72,16\r\n522.58,855.38,16\r\n522.58,727.32,16\r\n522.58,626.27,16\r\n522.58,463.21,16\r\n522.58,303.18,16\r\n	abs_VP2P105_MRM_transitions_optV_set12.csv	2009-08-05 10:29:23
112	MRM Transition List	abs_VP2P105_MRM_transitions_plus3V_set1	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.,Collision energy is plus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n488.73,701.32,20\r\n488.73,630.28,20\r\n488.73,573.26,20\r\n488.73,458.24,20\r\n488.73,343.21,20\r\n599.86,881.53,23\r\n599.86,784.48,23\r\n599.86,697.45,23\r\n599.86,584.36,23\r\n599.86,485.29,23\r\n599.86,272.17,23\r\n586.29,1034.51,23\r\n586.29,906.45,23\r\n586.29,849.43,23\r\n586.29,750.36,23\r\n586.29,619.32,23\r\n758.38,1216.59,28\r\n758.38,1079.53,28\r\n758.38,942.47,28\r\n758.38,841.42,28\r\n758.38,694.35,28\r\n1085.21,1251.64,35\r\n1085.21,1063.06,35\r\n1085.21,1277.72,35\r\n1085.21,753.39,35\r\n1085.21,553.27,35\r\n1085.21,390.21,35\r\n895.95,1411.75,32\r\n895.95,1086.59,32\r\n895.95,802.44,32\r\n895.95,689.36,32\r\n895.95,588.31,32\r\n895.95,475.23,32\r\n895.95,1298.67,32\r\n1061.88,1356.68,34\r\n1061.88,1291.16,34\r\n1061.88,806.95,34\r\n1061.88,1110.64,34\r\n1061.88,819.52,34\r\n1061.88,706.44,34\r\n977.54,1291.76,35\r\n977.54,1095.64,35\r\n977.54,869.47,35\r\n977.54,639.38,35\r\n977.54,568.35,35\r\n977.54,471.29,35\r\n	abs_VP2P105_MRM_transitions_plus3V_set1.csv	2009-08-05 10:32:54
113	MRM Transition List	abs_VP2P105_MRM_transitions_plus3V_set2	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.,Collision energy is plus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n1346.3,1312.7,42\r\n1346.3,1241.66,42\r\n1346.3,1113.67,42\r\n1346.3,1044.51,42\r\n1346.3,759.38,42\r\n917.46,1406.68,33\r\n917.46,1335.64,33\r\n917.46,1248.61,33\r\n917.46,1088.58,33\r\n917.46,987.53,33\r\n882.4,1264.52,32\r\n882.4,1101.46,32\r\n882.4,986.43,32\r\n882.4,743.35,32\r\n882.4,596.28,32\r\n865.79,1192.11,29\r\n865.79,1301.69,29\r\n865.79,1170.65,29\r\n865.79,968.55,29\r\n865.79,661.39,29\r\n765.9,1233.63,28\r\n765.9,1162.59,28\r\n765.9,1048.55,28\r\n765.9,949.48,28\r\n765.9,862.45,28\r\n765.9,549.28,28\r\n808.42,1318.63,30\r\n808.42,1219.56,30\r\n808.42,1104.54,30\r\n808.42,991.45,30\r\n808.42,862.41,30\r\n660.36,860.49,25\r\n660.36,713.42,25\r\n660.36,626.39,25\r\n660.36,527.32,25\r\n660.36,428.25,25\r\n810.92,1370.69,30\r\n810.92,1223.62,30\r\n810.92,1076.56,30\r\n810.92,945.52,30\r\n810.92,573.34,30\r\n533.22,820.34,21\r\n533.22,689.3,21\r\n533.22,618.27,21\r\n533.22,547.23,21\r\n533.22,794.26,21\r\n848.92,1245.66,31\r\n848.92,870.48,31\r\n848.92,684.4,31\r\n848.92,571.32,31\r\n848.92,1126.52,31\r\n933.45,1327.65,30\r\n933.45,1113.05,30\r\n933.45,618.79,30\r\n933.45,1236.58,30\r\n933.45,1089.51,30\r\n933.45,760.37,30\r\n933.45,689.34,30\r\n	abs_VP2P105_MRM_transitions_plus3V_set2.csv	2009-08-05 10:33:11
114	MRM Transition List	abs_VP2P105_MRM_transitions_plus3V_set3	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.,Collision energy is plus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n692.31,1099.47,26\r\n692.31,971.41,26\r\n692.31,856.38,26\r\n692.31,437.25,26\r\n692.31,338.18,26\r\n689.83,1182.52,26\r\n689.83,1081.48,26\r\n689.83,982.41,26\r\n689.83,822.38,26\r\n689.83,723.31,26\r\n526.76,995.49,21\r\n526.76,898.44,21\r\n526.76,801.39,21\r\n526.76,730.35,21\r\n526.76,616.31,21\r\n526.76,559.28,21\r\n526.76,488.25,21\r\n526.76,359.2,21\r\n526.76,262.15,21\r\n490.26,922.49,20\r\n490.26,759.43,20\r\n490.26,646.34,20\r\n490.26,559.31,20\r\n490.26,462.26,20\r\n490.26,347.23,20\r\n490.26,234.15,20\r\n929.44,1233.63,33\r\n929.44,1120.54,33\r\n929.44,1006.5,33\r\n929.44,674.38,33\r\n929.44,561.3,33\r\n739.35,1378.62,28\r\n739.35,1281.57,28\r\n739.35,1180.52,28\r\n739.35,1049.48,28\r\n739.35,889.45,28\r\n739.35,790.38,28\r\n739.35,675.36,28\r\n739.35,489.28,28\r\n739.35,402.25,28\r\n739.35,288.2,28\r\n	abs_VP2P105_MRM_transitions_plus3V_set3.csv	2009-08-05 10:33:28
115	MRM Transition List	abs_VP2P105_MRM_transitions_plus3V_set4	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.,Collision energy is plus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n767.39,1335.63,28\r\n767.39,1220.61,28\r\n767.39,1123.55,28\r\n767.39,1022.51,28\r\n767.39,925.45,28\r\n767.39,796.41,28\r\n767.39,668.35,28\r\n767.39,521.28,28\r\n767.39,393.22,28\r\n767.39,322.19,28\r\n1015,1342.68,36\r\n1015,1205.62,36\r\n1015,1074.58,36\r\n1015,975.51,36\r\n1015,888.48,36\r\n1015,787.43,36\r\n1015,686.38,36\r\n1015,573.3,36\r\n1015,476.25,36\r\n1015,377.18,36\r\n677.01,971.49,23\r\n677.01,920.97,23\r\n677.01,877.45,23\r\n677.01,826.93,23\r\n677.01,778.4,23\r\n677.01,721.38,23\r\n677.01,671.84,23\r\n677.01,603.31,23\r\n677.01,537.79,23\r\n677.01,488.26,23\r\n677.01,1205.62,23\r\n677.01,1074.58,23\r\n677.01,975.51,23\r\n677.01,888.48,23\r\n677.01,787.43,23\r\n677.01,686.38,23\r\n677.01,573.3,23\r\n677.01,476.25,23\r\n677.01,377.18,23\r\n677.01,262.15,23\r\n433.75,719.42,18\r\n433.75,606.34,18\r\n433.75,493.25,18\r\n433.75,379.21,18\r\n433.75,322.19,18\r\n	abs_VP2P105_MRM_transitions_plus3V_set4.csv	2009-08-05 10:34:03
116	MRM Transition List	abs_VP2P105_MRM_transitions_plus3V_set5	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.,Collision energy is plus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n485.75,869.45,20\r\n485.75,756.37,20\r\n485.75,669.34,20\r\n485.75,555.29,20\r\n485.75,498.27,20\r\n485.75,351.2,20\r\n485.75,294.18,20\r\n1370.64,1328.66,47\r\n1370.64,1214.62,47\r\n1370.64,1100.57,47\r\n1370.64,987.49,47\r\n1370.64,900.46,47\r\n1370.64,803.41,47\r\n1370.64,702.36,47\r\n1370.64,645.34,47\r\n1370.64,459.26,47\r\n1370.64,372.22,47\r\n914.1,1327.13,30\r\n914.1,1258.6,30\r\n914.1,1215.08,30\r\n914.1,1150.56,30\r\n914.1,1107.05,30\r\n914.1,1071.53,30\r\n914.1,1028.01,30\r\n914.1,979.48,30\r\n914.1,935.97,30\r\n914.1,900.45,30\r\n914.1,1328.66,30\r\n914.1,1214.62,30\r\n914.1,1100.57,30\r\n914.1,987.49,30\r\n914.1,900.46,30\r\n914.1,803.41,30\r\n914.1,702.36,30\r\n914.1,645.34,30\r\n914.1,459.26,30\r\n914.1,372.22,30\r\n914.1,244.17,30\r\n466.77,720.37,19\r\n466.77,649.33,19\r\n466.77,534.31,19\r\n466.77,786.42,19\r\n466.77,658.32,19\r\n	abs_VP2P105_MRM_transitions_plus3V_set5.csv	2009-08-05 10:34:20
117	MRM Transition List	abs_VP2P105_MRM_transitions_plus3V_set6	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.,Collision energy is plus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n674.37,1234.64,26\r\n674.37,1147.61,26\r\n674.37,1018.57,26\r\n674.37,905.48,26\r\n674.37,848.46,26\r\n674.37,777.43,26\r\n674.37,720.4,26\r\n674.37,606.36,26\r\n674.37,549.34,26\r\n674.37,492.32,26\r\n647.81,1009.48,25\r\n647.81,896.4,25\r\n647.81,768.31,25\r\n647.81,538.25,25\r\n647.81,423.22,25\r\n913.97,1373.67,33\r\n913.97,1226.61,33\r\n913.97,1139.57,33\r\n913.97,1026.49,33\r\n913.97,897.45,33\r\n674.34,1159.6,26\r\n674.34,1030.55,26\r\n674.34,917.47,26\r\n674.34,802.44,26\r\n674.34,731.41,26\r\n674.34,674.38,26\r\n674.34,560.34,26\r\n674.34,503.32,26\r\n674.34,446.3,26\r\n674.34,347.23,26\r\n736.89,1230.65,28\r\n736.89,1101.61,28\r\n736.89,1030.57,28\r\n736.89,917.48,28\r\n736.89,770.42,28\r\n736.89,713.39,28\r\n736.89,585.34,28\r\n736.89,488.28,28\r\n736.89,389.21,28\r\n736.89,290.15,28\r\n912.93,1224.57,33\r\n912.93,1095.53,33\r\n912.93,996.46,33\r\n912.93,881.43,33\r\n912.93,734.37,33\r\n912.93,663.33,33\r\n912.93,606.31,33\r\n834.88,1224.57,30\r\n834.88,1095.53,30\r\n834.88,996.46,30\r\n834.88,881.43,30\r\n834.88,734.37,30\r\n834.88,663.33,30\r\n834.88,606.31,30\r\n	abs_VP2P105_MRM_transitions_plus3V_set6.csv	2009-08-05 10:34:39
118	MRM Transition List	abs_VP2P105_MRM_transitions_plus3V_set7	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.,Collision energy is plus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n449.77,785.44,19\r\n449.77,688.39,19\r\n449.77,559.35,19\r\n449.77,430.3,19\r\n449.77,317.22,19\r\n449.77,204.13,19\r\n492.27,870.44,20\r\n492.27,756.4,20\r\n492.27,628.34,20\r\n492.27,531.29,20\r\n492.27,474.27,20\r\n492.27,373.22,20\r\n492.27,276.17,20\r\n651.92,1189.74,25\r\n651.92,1076.66,25\r\n651.92,939.6,25\r\n651.92,826.51,25\r\n651.92,697.47,25\r\n651.92,584.39,25\r\n651.92,456.29,25\r\n715.96,1189.74,27\r\n715.96,1076.66,27\r\n715.96,939.6,27\r\n715.96,826.51,27\r\n715.96,697.47,27\r\n715.96,584.39,27\r\n715.96,456.29,27\r\n1187.56,1410.7,41\r\n1187.56,1297.62,41\r\n1187.56,1069.51,41\r\n1187.56,851.44,41\r\n1187.56,780.4,41\r\n499.27,834.47,20\r\n499.27,737.42,20\r\n499.27,624.34,20\r\n499.27,527.28,20\r\n499.27,430.23,20\r\n499.27,333.18,20\r\n499.27,218.15,20\r\n926.47,1371.66,33\r\n926.47,1224.59,33\r\n926.47,1123.54,33\r\n926.47,1026.49,33\r\n926.47,911.46,33\r\n926.47,764.39,33\r\n926.47,636.34,33\r\n926.47,507.29,33\r\n926.47,360.22,33\r\n926.47,261.16,33\r\n	abs_VP2P105_MRM_transitions_plus3V_set7.csv	2009-08-05 10:34:58
119	MRM Transition List	abs_VP2P105_MRM_transitions_plus3V_set8	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.,Collision energy is plus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n554.29,978.53,22\r\n554.29,865.44,22\r\n554.29,752.36,22\r\n554.29,605.29,22\r\n554.29,476.25,22\r\n554.29,347.2,22\r\n554.29,246.16,22\r\n855.48,1406.78,31\r\n855.48,1269.72,31\r\n855.48,1140.67,31\r\n855.48,913.55,31\r\n855.48,800.46,31\r\n570.65,781.94,20\r\n570.65,703.89,20\r\n570.65,635.36,20\r\n570.65,570.84,20\r\n570.65,513.82,20\r\n570.65,913.55,20\r\n570.65,800.46,20\r\n570.65,743.44,20\r\n570.65,630.36,20\r\n570.65,516.31,20\r\n487.76,917.48,20\r\n487.76,789.43,20\r\n487.76,690.36,20\r\n487.76,543.29,20\r\n487.76,428.26,20\r\n487.76,329.19,20\r\n487.76,272.17,20\r\n674.88,1107.57,26\r\n674.88,978.53,26\r\n674.88,865.44,26\r\n674.88,752.36,26\r\n674.88,605.29,26\r\n674.88,476.25,26\r\n450.25,618.34,17\r\n450.25,554.29,17\r\n450.25,489.77,17\r\n450.25,433.22,17\r\n450.25,376.68,17\r\n450.25,303.15,17\r\n450.25,1107.57,17\r\n450.25,978.53,17\r\n450.25,865.44,17\r\n450.25,752.36,17\r\n	abs_VP2P105_MRM_transitions_plus3V_set8.csv	2009-08-05 10:35:10
120	MRM Transition List	abs_VP2P105_MRM_transitions_plus3V_set9	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.,Collision energy is plus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n703.89,1269.72,27\r\n703.89,1140.67,27\r\n703.89,1026.63,27\r\n703.89,913.55,27\r\n703.89,800.46,27\r\n703.89,743.44,27\r\n703.89,630.36,27\r\n703.89,516.31,27\r\n703.89,401.29,27\r\n703.89,288.2,27\r\n469.6,635.36,18\r\n469.6,570.84,18\r\n469.6,513.82,18\r\n469.6,457.28,18\r\n469.6,400.74,18\r\n469.6,372.22,18\r\n469.6,315.68,18\r\n469.6,258.66,18\r\n469.6,201.15,18\r\n469.6,144.61,18\r\n469.6,1269.72,18\r\n469.6,1140.67,18\r\n469.6,1026.63,18\r\n469.6,913.55,18\r\n469.6,800.46,18\r\n469.6,743.44,18\r\n469.6,630.36,18\r\n469.6,516.31,18\r\n469.6,401.29,18\r\n469.6,288.2,18\r\n897.07,1357.59,29\r\n897.07,1169.53,29\r\n897.07,974.43,29\r\n897.07,917.89,29\r\n897.07,760.83,29\r\n982.12,1227.07,32\r\n982.12,1183.55,32\r\n982.12,1102.02,32\r\n982.12,1045.48,32\r\n982.12,952.44,32\r\n	abs_VP2P105_MRM_transitions_plus3V_set9.csv	2009-08-05 10:35:40
121	MRM Transition List	abs_VP2P105_MRM_transitions_plus3V_set10	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.,Collision energy is plus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n1072.51,1257.65,38\r\n1072.51,1156.6,38\r\n1072.51,1099.58,38\r\n1072.51,952.51,38\r\n1072.51,839.43,38\r\n1072.51,738.38,38\r\n1072.51,609.34,38\r\n1072.51,446.27,38\r\n1072.51,347.2,38\r\n1072.51,276.17,38\r\n715.34,1022.97,24\r\n715.34,987.45,24\r\n715.34,929.94,24\r\n715.34,881.41,24\r\n715.34,823.9,24\r\n715.34,755.37,24\r\n715.34,697.86,24\r\n715.34,629.33,24\r\n715.34,578.8,24\r\n715.34,550.29,24\r\n715.34,1257.65,24\r\n715.34,1156.6,24\r\n715.34,1099.58,24\r\n715.34,952.51,24\r\n715.34,839.43,24\r\n715.34,738.38,24\r\n715.34,609.34,24\r\n715.34,446.27,24\r\n715.34,347.2,24\r\n715.34,276.17,24\r\n1161.08,1275.66,40\r\n1161.08,952.56,40\r\n1161.08,805.49,40\r\n1161.08,692.41,40\r\n1161.08,529.35,40\r\n774.39,1275.66,26\r\n774.39,1115.63,26\r\n774.39,1046.53,26\r\n774.39,978,26\r\n774.39,921.45,26\r\n	abs_VP2P105_MRM_transitions_plus3V_set10.csv	2009-08-05 10:35:52
122	MRM Transition List	abs_VP2P105_MRM_transitions_plus3V_set11	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.,Collision energy is plus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n1149.57,1388.74,40\r\n1149.57,1275.66,40\r\n1149.57,952.56,40\r\n1149.57,805.49,40\r\n1149.57,692.41,40\r\n766.72,1042.03,26\r\n766.72,978,26\r\n766.72,921.45,26\r\n766.72,1275.66,26\r\n766.72,1115.63,26\r\n766.72,529.35,26\r\n766.72,401.29,26\r\n442.78,755.51,19\r\n442.78,642.43,19\r\n442.78,514.37,19\r\n442.78,401.29,19\r\n442.78,288.2,19\r\n553.8,977.54,22\r\n553.8,864.46,22\r\n553.8,751.37,22\r\n553.8,604.31,22\r\n553.8,476.25,22\r\n553.8,347.2,22\r\n553.8,246.16,22\r\n486.75,915.47,20\r\n486.75,787.41,20\r\n486.75,690.36,20\r\n486.75,543.29,20\r\n486.75,428.26,20\r\n486.75,329.19,20\r\n486.75,272.17,20\r\n1086.52,1257.65,38\r\n1086.52,1156.6,38\r\n1086.52,1099.58,38\r\n1086.52,952.51,38\r\n1086.52,839.43,38\r\n1086.52,738.38,38\r\n1086.52,609.34,38\r\n1086.52,446.27,38\r\n1086.52,347.2,38\r\n1086.52,276.17,38\r\n724.68,1029.98,25\r\n724.68,994.46,25\r\n724.68,936.95,25\r\n724.68,888.42,25\r\n724.68,823.9,25\r\n724.68,755.37,25\r\n724.68,697.86,25\r\n724.68,1257.65,25\r\n724.68,1156.6,25\r\n724.68,1099.58,25\r\n724.68,952.51,25\r\n724.68,839.43,25\r\n724.68,738.38,25\r\n724.68,609.34,25\r\n724.68,446.27,25\r\n724.68,347.2,25\r\n724.68,276.17,25\r\n	abs_VP2P105_MRM_transitions_plus3V_set11.csv	2009-08-05 10:36:02
123	MRM Transition List	abs_VP2P105_MRM_transitions_plus3V_set12	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.,Collision energy is plus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n922.99,1391.72,33\r\n922.99,1190.64,33\r\n922.99,1077.56,33\r\n922.99,964.48,33\r\n922.99,851.39,33\r\n605.33,933.5,24\r\n605.33,796.44,24\r\n605.33,709.41,24\r\n605.33,638.37,24\r\n605.33,524.33,24\r\n403.89,523.8,16\r\n403.89,467.25,16\r\n403.89,398.73,16\r\n403.89,355.21,16\r\n403.89,319.69,16\r\n403.89,262.67,16\r\n403.89,213.14,16\r\n403.89,156.59,16\r\n403.89,1046.59,16\r\n403.89,933.5,16\r\n403.89,796.44,16\r\n403.89,709.41,16\r\n403.89,638.37,16\r\n403.89,524.33,16\r\n403.89,425.26,16\r\n403.89,312.18,16\r\n783.36,1121.48,29\r\n783.36,992.44,29\r\n783.36,855.38,29\r\n783.36,727.32,29\r\n783.36,626.27,29\r\n783.36,463.21,29\r\n522.58,726.82,19\r\n522.58,683.3,19\r\n522.58,634.78,19\r\n522.58,561.24,19\r\n522.58,496.72,19\r\n522.58,855.38,19\r\n522.58,727.32,19\r\n522.58,626.27,19\r\n522.58,463.21,19\r\n522.58,303.18,19\r\n	abs_VP2P105_MRM_transitions_plus3V_set12.csv	2009-08-05 10:36:13
124	MRM Transition List	abs_VP2P105_MRM_transitions_min3V_set1	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets. Collision energy is minus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n488.73,701.32,14\r\n488.73,630.28,14\r\n488.73,573.26,14\r\n488.73,458.24,14\r\n488.73,343.21,14\r\n599.86,881.53,17\r\n599.86,784.48,17\r\n599.86,697.45,17\r\n599.86,584.36,17\r\n599.86,485.29,17\r\n599.86,272.17,17\r\n586.29,1034.51,17\r\n586.29,906.45,17\r\n586.29,849.43,17\r\n586.29,750.36,17\r\n586.29,619.32,17\r\n758.38,1216.59,22\r\n758.38,1079.53,22\r\n758.38,942.47,22\r\n758.38,841.42,22\r\n758.38,694.35,22\r\n1085.21,1251.64,29\r\n1085.21,1063.06,29\r\n1085.21,1277.72,29\r\n1085.21,753.39,29\r\n1085.21,553.27,29\r\n1085.21,390.21,29\r\n895.95,1411.75,26\r\n895.95,1086.59,26\r\n895.95,802.44,26\r\n895.95,689.36,26\r\n895.95,588.31,26\r\n895.95,475.23,26\r\n895.95,1298.67,26\r\n1061.88,1356.68,28\r\n1061.88,1291.16,28\r\n1061.88,806.95,28\r\n1061.88,1110.64,28\r\n1061.88,819.52,28\r\n1061.88,706.44,28\r\n977.54,1291.76,29\r\n977.54,1095.64,29\r\n977.54,869.47,29\r\n977.54,639.38,29\r\n977.54,568.35,29\r\n977.54,471.29,29\r\n	abs_VP2P105_MRM_transitions_min3V_set1.csv	2009-08-05 10:39:50
125	MRM Transition List	abs_VP2P105_MRM_transitions_min3V_set2	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets. Collision energy is minus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n1346.3,1312.7,36\r\n1346.3,1241.66,36\r\n1346.3,1113.67,36\r\n1346.3,1044.51,36\r\n1346.3,759.38,36\r\n917.46,1406.68,27\r\n917.46,1335.64,27\r\n917.46,1248.61,27\r\n917.46,1088.58,27\r\n917.46,987.53,27\r\n882.4,1264.52,26\r\n882.4,1101.46,26\r\n882.4,986.43,26\r\n882.4,743.35,26\r\n882.4,596.28,26\r\n865.79,1192.11,23\r\n865.79,1301.69,23\r\n865.79,1170.65,23\r\n865.79,968.55,23\r\n865.79,661.39,23\r\n765.9,1233.63,22\r\n765.9,1162.59,22\r\n765.9,1048.55,22\r\n765.9,949.48,22\r\n765.9,862.45,22\r\n765.9,549.28,22\r\n808.42,1318.63,24\r\n808.42,1219.56,24\r\n808.42,1104.54,24\r\n808.42,991.45,24\r\n808.42,862.41,24\r\n660.36,860.49,19\r\n660.36,713.42,19\r\n660.36,626.39,19\r\n660.36,527.32,19\r\n660.36,428.25,19\r\n810.92,1370.69,24\r\n810.92,1223.62,24\r\n810.92,1076.56,24\r\n810.92,945.52,24\r\n810.92,573.34,24\r\n533.22,820.34,15\r\n533.22,689.3,15\r\n533.22,618.27,15\r\n533.22,547.23,15\r\n533.22,794.26,15\r\n848.92,1245.66,25\r\n848.92,870.48,25\r\n848.92,684.4,25\r\n848.92,571.32,25\r\n848.92,1126.52,25\r\n933.45,1327.65,24\r\n933.45,1113.05,24\r\n933.45,618.79,24\r\n933.45,1236.58,24\r\n933.45,1089.51,24\r\n933.45,760.37,24\r\n933.45,689.34,24\r\n	abs_VP2P105_MRM_transitions_min3V_set2.csv	2009-08-05 10:39:59
126	MRM Transition List	abs_VP2P105_MRM_transitions_min3V_set3	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets. Collision energy is minus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n692.31,1099.47,20\r\n692.31,971.41,20\r\n692.31,856.38,20\r\n692.31,437.25,20\r\n692.31,338.18,20\r\n689.83,1182.52,20\r\n689.83,1081.48,20\r\n689.83,982.41,20\r\n689.83,822.38,20\r\n689.83,723.31,20\r\n526.76,995.49,15\r\n526.76,898.44,15\r\n526.76,801.39,15\r\n526.76,730.35,15\r\n526.76,616.31,15\r\n526.76,559.28,15\r\n526.76,488.25,15\r\n526.76,359.2,15\r\n526.76,262.15,15\r\n490.26,922.49,14\r\n490.26,759.43,14\r\n490.26,646.34,14\r\n490.26,559.31,14\r\n490.26,462.26,14\r\n490.26,347.23,14\r\n490.26,234.15,14\r\n929.44,1233.63,27\r\n929.44,1120.54,27\r\n929.44,1006.5,27\r\n929.44,674.38,27\r\n929.44,561.3,27\r\n739.35,1378.62,22\r\n739.35,1281.57,22\r\n739.35,1180.52,22\r\n739.35,1049.48,22\r\n739.35,889.45,22\r\n739.35,790.38,22\r\n739.35,675.36,22\r\n739.35,489.28,22\r\n739.35,402.25,22\r\n739.35,288.2,22\r\n	abs_VP2P105_MRM_transitions_min3V_set3.csv	2009-08-05 10:40:08
127	MRM Transition List	abs_VP2P105_MRM_transitions_min3V_set4	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets. Collision energy is minus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n767.39,1335.63,22\r\n767.39,1220.61,22\r\n767.39,1123.55,22\r\n767.39,1022.51,22\r\n767.39,925.45,22\r\n767.39,796.41,22\r\n767.39,668.35,22\r\n767.39,521.28,22\r\n767.39,393.22,22\r\n767.39,322.19,22\r\n1015,1342.68,30\r\n1015,1205.62,30\r\n1015,1074.58,30\r\n1015,975.51,30\r\n1015,888.48,30\r\n1015,787.43,30\r\n1015,686.38,30\r\n1015,573.3,30\r\n1015,476.25,30\r\n1015,377.18,30\r\n677.01,971.49,17\r\n677.01,920.97,17\r\n677.01,877.45,17\r\n677.01,826.93,17\r\n677.01,778.4,17\r\n677.01,721.38,17\r\n677.01,671.84,17\r\n677.01,603.31,17\r\n677.01,537.79,17\r\n677.01,488.26,17\r\n677.01,1205.62,17\r\n677.01,1074.58,17\r\n677.01,975.51,17\r\n677.01,888.48,17\r\n677.01,787.43,17\r\n677.01,686.38,17\r\n677.01,573.3,17\r\n677.01,476.25,17\r\n677.01,377.18,17\r\n677.01,262.15,17\r\n433.75,719.42,12\r\n433.75,606.34,12\r\n433.75,493.25,12\r\n433.75,379.21,12\r\n433.75,322.19,12\r\n	abs_VP2P105_MRM_transitions_min3V_set4.csv	2009-08-05 10:40:15
128	MRM Transition List	abs_VP2P105_MRM_transitions_min3V_set5	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets. Collision energy is minus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n485.75,869.45,14\r\n485.75,756.37,14\r\n485.75,669.34,14\r\n485.75,555.29,14\r\n485.75,498.27,14\r\n485.75,351.2,14\r\n485.75,294.18,14\r\n1370.64,1328.66,41\r\n1370.64,1214.62,41\r\n1370.64,1100.57,41\r\n1370.64,987.49,41\r\n1370.64,900.46,41\r\n1370.64,803.41,41\r\n1370.64,702.36,41\r\n1370.64,645.34,41\r\n1370.64,459.26,41\r\n1370.64,372.22,41\r\n914.1,1327.13,24\r\n914.1,1258.6,24\r\n914.1,1215.08,24\r\n914.1,1150.56,24\r\n914.1,1107.05,24\r\n914.1,1071.53,24\r\n914.1,1028.01,24\r\n914.1,979.48,24\r\n914.1,935.97,24\r\n914.1,900.45,24\r\n914.1,1328.66,24\r\n914.1,1214.62,24\r\n914.1,1100.57,24\r\n914.1,987.49,24\r\n914.1,900.46,24\r\n914.1,803.41,24\r\n914.1,702.36,24\r\n914.1,645.34,24\r\n914.1,459.26,24\r\n914.1,372.22,24\r\n914.1,244.17,24\r\n466.77,720.37,13\r\n466.77,649.33,13\r\n466.77,534.31,13\r\n466.77,786.42,13\r\n466.77,658.32,13\r\n	abs_VP2P105_MRM_transitions_min3V_set5.csv	2009-08-05 10:40:24
129	MRM Transition List	abs_VP2P105_MRM_transitions_min3V_set6	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets. Collision energy is minus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n674.37,1234.64,20\r\n674.37,1147.61,20\r\n674.37,1018.57,20\r\n674.37,905.48,20\r\n674.37,848.46,20\r\n674.37,777.43,20\r\n674.37,720.4,20\r\n674.37,606.36,20\r\n674.37,549.34,20\r\n674.37,492.32,20\r\n647.81,1009.48,19\r\n647.81,896.4,19\r\n647.81,768.31,19\r\n647.81,538.25,19\r\n647.81,423.22,19\r\n913.97,1373.67,27\r\n913.97,1226.61,27\r\n913.97,1139.57,27\r\n913.97,1026.49,27\r\n913.97,897.45,27\r\n674.34,1159.6,20\r\n674.34,1030.55,20\r\n674.34,917.47,20\r\n674.34,802.44,20\r\n674.34,731.41,20\r\n674.34,674.38,20\r\n674.34,560.34,20\r\n674.34,503.32,20\r\n674.34,446.3,20\r\n674.34,347.23,20\r\n736.89,1230.65,22\r\n736.89,1101.61,22\r\n736.89,1030.57,22\r\n736.89,917.48,22\r\n736.89,770.42,22\r\n736.89,713.39,22\r\n736.89,585.34,22\r\n736.89,488.28,22\r\n736.89,389.21,22\r\n736.89,290.15,22\r\n912.93,1224.57,27\r\n912.93,1095.53,27\r\n912.93,996.46,27\r\n912.93,881.43,27\r\n912.93,734.37,27\r\n912.93,663.33,27\r\n912.93,606.31,27\r\n834.88,1224.57,24\r\n834.88,1095.53,24\r\n834.88,996.46,24\r\n834.88,881.43,24\r\n834.88,734.37,24\r\n834.88,663.33,24\r\n834.88,606.31,24\r\n	abs_VP2P105_MRM_transitions_min3V_set6.csv	2009-08-05 10:40:33
131	MRM Transition List	abs_VP2P105_MRM_transitions_min3V_set8	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets. Collision energy is minus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n554.29,978.53,16\r\n554.29,865.44,16\r\n554.29,752.36,16\r\n554.29,605.29,16\r\n554.29,476.25,16\r\n554.29,347.2,16\r\n554.29,246.16,16\r\n855.48,1406.78,25\r\n855.48,1269.72,25\r\n855.48,1140.67,25\r\n855.48,913.55,25\r\n855.48,800.46,25\r\n570.65,781.94,14\r\n570.65,703.89,14\r\n570.65,635.36,14\r\n570.65,570.84,14\r\n570.65,513.82,14\r\n570.65,913.55,14\r\n570.65,800.46,14\r\n570.65,743.44,14\r\n570.65,630.36,14\r\n570.65,516.31,14\r\n487.76,917.48,14\r\n487.76,789.43,14\r\n487.76,690.36,14\r\n487.76,543.29,14\r\n487.76,428.26,14\r\n487.76,329.19,14\r\n487.76,272.17,14\r\n674.88,1107.57,20\r\n674.88,978.53,20\r\n674.88,865.44,20\r\n674.88,752.36,20\r\n674.88,605.29,20\r\n674.88,476.25,20\r\n450.25,618.34,11\r\n450.25,554.29,11\r\n450.25,489.77,11\r\n450.25,433.22,11\r\n450.25,376.68,11\r\n450.25,303.15,11\r\n450.25,1107.57,11\r\n450.25,978.53,11\r\n450.25,865.44,11\r\n450.25,752.36,11\r\n	abs_VP2P105_MRM_transitions_min3V_set8.csv	2009-08-05 10:40:49
132	MRM Transition List	abs_VP2P105_MRM_transitions_min3V_set9	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets. Collision energy is minus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n703.89,1269.72,21\r\n703.89,1140.67,21\r\n703.89,1026.63,21\r\n703.89,913.55,21\r\n703.89,800.46,21\r\n703.89,743.44,21\r\n703.89,630.36,21\r\n703.89,516.31,21\r\n703.89,401.29,21\r\n703.89,288.2,21\r\n469.6,635.36,12\r\n469.6,570.84,12\r\n469.6,513.82,12\r\n469.6,457.28,12\r\n469.6,400.74,12\r\n469.6,372.22,12\r\n469.6,315.68,12\r\n469.6,258.66,12\r\n469.6,201.15,12\r\n469.6,144.61,12\r\n469.6,1269.72,12\r\n469.6,1140.67,12\r\n469.6,1026.63,12\r\n469.6,913.55,12\r\n469.6,800.46,12\r\n469.6,743.44,12\r\n469.6,630.36,12\r\n469.6,516.31,12\r\n469.6,401.29,12\r\n469.6,288.2,12\r\n897.07,1357.59,23\r\n897.07,1169.53,23\r\n897.07,974.43,23\r\n897.07,917.89,23\r\n897.07,760.83,23\r\n982.12,1227.07,26\r\n982.12,1183.55,26\r\n982.12,1102.02,26\r\n982.12,1045.48,26\r\n982.12,952.44,26\r\n	abs_VP2P105_MRM_transitions_min3V_set9.csv	2009-08-05 10:40:58
133	MRM Transition List	abs_VP2P105_MRM_transitions_min3V_set10	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets. Collision energy is minus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n1072.51,1257.65,32\r\n1072.51,1156.6,32\r\n1072.51,1099.58,32\r\n1072.51,952.51,32\r\n1072.51,839.43,32\r\n1072.51,738.38,32\r\n1072.51,609.34,32\r\n1072.51,446.27,32\r\n1072.51,347.2,32\r\n1072.51,276.17,32\r\n715.34,1022.97,18\r\n715.34,987.45,18\r\n715.34,929.94,18\r\n715.34,881.41,18\r\n715.34,823.9,18\r\n715.34,755.37,18\r\n715.34,697.86,18\r\n715.34,629.33,18\r\n715.34,578.8,18\r\n715.34,550.29,18\r\n715.34,1257.65,18\r\n715.34,1156.6,18\r\n715.34,1099.58,18\r\n715.34,952.51,18\r\n715.34,839.43,18\r\n715.34,738.38,18\r\n715.34,609.34,18\r\n715.34,446.27,18\r\n715.34,347.2,18\r\n715.34,276.17,18\r\n1161.08,1275.66,34\r\n1161.08,952.56,34\r\n1161.08,805.49,34\r\n1161.08,692.41,34\r\n1161.08,529.35,34\r\n774.39,1275.66,20\r\n774.39,1115.63,20\r\n774.39,1046.53,20\r\n774.39,978,20\r\n774.39,921.45,20\r\n	abs_VP2P105_MRM_transitions_min3V_set10.csv	2009-08-05 10:41:07
134	MRM Transition List	abs_VP2P105_MRM_transitions_min3V_set11	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets. Collision energy is minus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n1149.57,1388.74,34\r\n1149.57,1275.66,34\r\n1149.57,952.56,34\r\n1149.57,805.49,34\r\n1149.57,692.41,34\r\n766.72,1042.03,20\r\n766.72,978,20\r\n766.72,921.45,20\r\n766.72,1275.66,20\r\n766.72,1115.63,20\r\n766.72,529.35,20\r\n766.72,401.29,20\r\n442.78,755.51,13\r\n442.78,642.43,13\r\n442.78,514.37,13\r\n442.78,401.29,13\r\n442.78,288.2,13\r\n553.8,977.54,16\r\n553.8,864.46,16\r\n553.8,751.37,16\r\n553.8,604.31,16\r\n553.8,476.25,16\r\n553.8,347.2,16\r\n553.8,246.16,16\r\n486.75,915.47,14\r\n486.75,787.41,14\r\n486.75,690.36,14\r\n486.75,543.29,14\r\n486.75,428.26,14\r\n486.75,329.19,14\r\n486.75,272.17,14\r\n1086.52,1257.65,32\r\n1086.52,1156.6,32\r\n1086.52,1099.58,32\r\n1086.52,952.51,32\r\n1086.52,839.43,32\r\n1086.52,738.38,32\r\n1086.52,609.34,32\r\n1086.52,446.27,32\r\n1086.52,347.2,32\r\n1086.52,276.17,32\r\n724.68,1029.98,19\r\n724.68,994.46,19\r\n724.68,936.95,19\r\n724.68,888.42,19\r\n724.68,823.9,19\r\n724.68,755.37,19\r\n724.68,697.86,19\r\n724.68,1257.65,19\r\n724.68,1156.6,19\r\n724.68,1099.58,19\r\n724.68,952.51,19\r\n724.68,839.43,19\r\n724.68,738.38,19\r\n724.68,609.34,19\r\n724.68,446.27,19\r\n724.68,347.2,19\r\n724.68,276.17,19\r\n	abs_VP2P105_MRM_transitions_min3V_set11.csv	2009-08-05 10:41:15
135	MRM Transition List	abs_VP2P105_MRM_transitions_min3V_set12	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets. Collision energy is minus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n922.99,1391.72,27\r\n922.99,1190.64,27\r\n922.99,1077.56,27\r\n922.99,964.48,27\r\n922.99,851.39,27\r\n605.33,933.5,18\r\n605.33,796.44,18\r\n605.33,709.41,18\r\n605.33,638.37,18\r\n605.33,524.33,18\r\n403.89,523.8,10\r\n403.89,467.25,10\r\n403.89,398.73,10\r\n403.89,355.21,10\r\n403.89,319.69,10\r\n403.89,262.67,10\r\n403.89,213.14,10\r\n403.89,156.59,10\r\n403.89,1046.59,10\r\n403.89,933.5,10\r\n403.89,796.44,10\r\n403.89,709.41,10\r\n403.89,638.37,10\r\n403.89,524.33,10\r\n403.89,425.26,10\r\n403.89,312.18,10\r\n783.36,1121.48,23\r\n783.36,992.44,23\r\n783.36,855.38,23\r\n783.36,727.32,23\r\n783.36,626.27,23\r\n783.36,463.21,23\r\n522.58,726.82,13\r\n522.58,683.3,13\r\n522.58,634.78,13\r\n522.58,561.24,13\r\n522.58,496.72,13\r\n522.58,855.38,13\r\n522.58,727.32,13\r\n522.58,626.27,13\r\n522.58,463.21,13\r\n522.58,303.18,13\r\n	abs_VP2P105_MRM_transitions_min3V_set12.csv	2009-08-05 10:41:22
108	MRM Transition List	abs_VP2P105_MRM_transitions_optV_set9	Transitions for the human proteins:,ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n703.89,1269.72,24\r\n703.89,1140.67,24\r\n703.89,1026.63,24\r\n703.89,913.55,24\r\n703.89,800.46,24\r\n703.89,743.44,24\r\n703.89,630.36,24\r\n703.89,516.31,24\r\n703.89,401.29,24\r\n703.89,288.2,24\r\n469.6,635.36,15\r\n469.6,570.84,15\r\n469.6,513.82,15\r\n469.6,457.28,15\r\n469.6,400.74,15\r\n469.6,372.22,15\r\n469.6,315.68,15\r\n469.6,258.66,15\r\n469.6,201.15,15\r\n469.6,144.61,15\r\n469.6,1269.72,15\r\n469.6,1140.67,15\r\n469.6,1026.63,15\r\n469.6,913.55,15\r\n469.6,800.46,15\r\n469.6,743.44,15\r\n469.6,630.36,15\r\n469.6,516.31,15\r\n469.6,401.29,15\r\n469.6,288.2,15\r\n897.07,1357.59,26\r\n897.07,1169.53,26\r\n897.07,974.43,26\r\n897.07,917.89,26\r\n897.07,760.83,26\r\n982.12,1227.07,29\r\n982.12,1183.55,29\r\n982.12,1102.02,29\r\n982.12,1045.48,29\r\n982.12,952.44,29\r\n	abs_VP2P105_MRM_transitions_optV_set9.csv	2009-08-05 10:28:28
130	MRM Transition List	abs_VP2P105_MRM_transitions_min3V_set7	Transitions for the human proteins: ACTB, ARAF, GAPDH, MAP2K1, MAP2K1/2, MAP2K2, MAPK1, MAPK1/3, MAPK3, RAF1, TUBB. Note, they are split into multiple sets. Collision energy is minus 3 Volts from the estimated optimum.	D3M629	Y	PARENT,FRAGMENT,VOLTAGE\r\n449.77,785.44,13\r\n449.77,688.39,13\r\n449.77,559.35,13\r\n449.77,430.3,13\r\n449.77,317.22,13\r\n449.77,204.13,13\r\n492.27,870.44,14\r\n492.27,756.4,14\r\n492.27,628.34,14\r\n492.27,531.29,14\r\n492.27,474.27,14\r\n492.27,373.22,14\r\n492.27,276.17,14\r\n651.92,1189.74,19\r\n651.92,1076.66,19\r\n651.92,939.6,19\r\n651.92,826.51,19\r\n651.92,697.47,19\r\n651.92,584.39,19\r\n651.92,456.29,19\r\n715.96,1189.74,21\r\n715.96,1076.66,21\r\n715.96,939.6,21\r\n715.96,826.51,21\r\n715.96,697.47,21\r\n715.96,584.39,21\r\n715.96,456.29,21\r\n1187.56,1410.7,35\r\n1187.56,1297.62,35\r\n1187.56,1069.51,35\r\n1187.56,851.44,35\r\n1187.56,780.4,35\r\n499.27,834.47,14\r\n499.27,737.42,14\r\n499.27,624.34,14\r\n499.27,527.28,14\r\n499.27,430.23,14\r\n499.27,333.18,14\r\n499.27,218.15,14\r\n926.47,1371.66,27\r\n926.47,1224.59,27\r\n926.47,1123.54,27\r\n926.47,1026.49,27\r\n926.47,911.46,27\r\n926.47,764.39,27\r\n926.47,636.34,27\r\n926.47,507.29,27\r\n926.47,360.22,27\r\n926.47,261.16,27\r\n	abs_VP2P105_MRM_transitions_min3V_set7.csv	2009-08-05 10:40:41
\.


--
-- Name: t_attachments_attachment_id_seq; Type: SEQUENCE SET; Schema: public; Owner: d3l243
--

SELECT pg_catalog.setval('public.t_attachments_attachment_id_seq', 137, true);


--
-- PostgreSQL database dump complete
--

